RS61611B1 - Upotreba kompozicije koja sadrži benzoat kod poremećaja ciklusa uree i neurodegenerativnih poremećaja - Google Patents
Upotreba kompozicije koja sadrži benzoat kod poremećaja ciklusa uree i neurodegenerativnih poremećajaInfo
- Publication number
- RS61611B1 RS61611B1 RS20210230A RSP20210230A RS61611B1 RS 61611 B1 RS61611 B1 RS 61611B1 RS 20210230 A RS20210230 A RS 20210230A RS P20210230 A RSP20210230 A RS P20210230A RS 61611 B1 RS61611 B1 RS 61611B1
- Authority
- RS
- Serbia
- Prior art keywords
- containing composition
- neurodegenerative disorders
- glyceryl tribenzoate
- tribenzoate
- glyceryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461928622P | 2014-01-17 | 2014-01-17 | |
| EP15737329.1A EP3094616B1 (en) | 2014-01-17 | 2015-01-16 | The use of glyceryl tribenzoate containing composition in neurodegenerative disorders |
| PCT/US2015/011798 WO2015109215A1 (en) | 2014-01-17 | 2015-01-16 | The use of a benzoate containing composition in urea cycle disorders and neurodegenerativre disordrs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS61611B1 true RS61611B1 (sr) | 2021-04-29 |
Family
ID=53543490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20210230A RS61611B1 (sr) | 2014-01-17 | 2015-01-16 | Upotreba kompozicije koja sadrži benzoat kod poremećaja ciklusa uree i neurodegenerativnih poremećaja |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9968582B2 (sr) |
| EP (1) | EP3094616B1 (sr) |
| JP (2) | JP6836905B2 (sr) |
| CA (1) | CA2936548C (sr) |
| CY (1) | CY1124115T1 (sr) |
| DK (1) | DK3094616T3 (sr) |
| ES (1) | ES2853974T3 (sr) |
| HR (1) | HRP20210361T1 (sr) |
| HU (1) | HUE053671T2 (sr) |
| LT (1) | LT3094616T (sr) |
| PL (1) | PL3094616T3 (sr) |
| PT (1) | PT3094616T (sr) |
| RS (1) | RS61611B1 (sr) |
| SI (1) | SI3094616T1 (sr) |
| WO (1) | WO2015109215A1 (sr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111212637A (zh) * | 2017-10-06 | 2020-05-29 | 拉什大学医学中心 | 含苯甲酸酯的组合物治疗甘氨酸脑病的用途 |
| TWI752282B (zh) | 2017-11-22 | 2022-01-11 | 林潔欣 | 苯甲酸或其鹽及衍生物用於預防或治療憂鬱症之用途 |
| US20220133664A1 (en) * | 2019-02-25 | 2022-05-05 | Rush University Medical Center | Compositions including cinnamic acid and methods of use thereof |
| CN114502154A (zh) * | 2019-07-16 | 2022-05-13 | 拉什大学医学中心 | 含苯甲酸酯的组合物治疗神经退行性疾病的用途 |
| CA3198826A1 (en) * | 2020-10-28 | 2022-05-05 | Rush University Medical Center | Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders |
| US20240100008A1 (en) * | 2020-12-16 | 2024-03-28 | Rush University Medical Center | Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| US20080171792A1 (en) | 2006-12-28 | 2008-07-17 | Jobdevairakkam Christopher New | Use of highly concentrated formulations of 4-phenylbutyrate for treatment of certain disorders |
-
2015
- 2015-01-16 DK DK15737329.1T patent/DK3094616T3/da active
- 2015-01-16 WO PCT/US2015/011798 patent/WO2015109215A1/en active Application Filing
- 2015-01-16 JP JP2016565117A patent/JP6836905B2/ja active Active
- 2015-01-16 HU HUE15737329A patent/HUE053671T2/hu unknown
- 2015-01-16 PL PL15737329T patent/PL3094616T3/pl unknown
- 2015-01-16 SI SI201531511T patent/SI3094616T1/sl unknown
- 2015-01-16 US US15/110,702 patent/US9968582B2/en active Active
- 2015-01-16 PT PT157373291T patent/PT3094616T/pt unknown
- 2015-01-16 CA CA2936548A patent/CA2936548C/en active Active
- 2015-01-16 ES ES15737329T patent/ES2853974T3/es active Active
- 2015-01-16 LT LTEP15737329.1T patent/LT3094616T/lt unknown
- 2015-01-16 RS RS20210230A patent/RS61611B1/sr unknown
- 2015-01-16 EP EP15737329.1A patent/EP3094616B1/en active Active
-
2019
- 2019-10-18 JP JP2019191224A patent/JP2020037558A/ja active Pending
-
2021
- 2021-03-03 HR HRP20210361TT patent/HRP20210361T1/hr unknown
- 2021-03-09 CY CY20211100204T patent/CY1124115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3094616A1 (en) | 2016-11-23 |
| US20160331714A1 (en) | 2016-11-17 |
| PL3094616T3 (pl) | 2021-05-31 |
| HRP20210361T1 (hr) | 2021-04-16 |
| WO2015109215A1 (en) | 2015-07-23 |
| JP6836905B2 (ja) | 2021-03-03 |
| PT3094616T (pt) | 2021-03-03 |
| CA2936548C (en) | 2022-08-30 |
| CA2936548A1 (en) | 2015-07-23 |
| US9968582B2 (en) | 2018-05-15 |
| ES2853974T3 (es) | 2021-09-20 |
| JP2017505811A (ja) | 2017-02-23 |
| EP3094616A4 (en) | 2017-08-23 |
| CY1124115T1 (el) | 2022-05-27 |
| JP2020037558A (ja) | 2020-03-12 |
| HUE053671T2 (hu) | 2021-07-28 |
| DK3094616T3 (da) | 2021-02-15 |
| EP3094616B1 (en) | 2020-12-23 |
| LT3094616T (lt) | 2021-04-12 |
| SI3094616T1 (sl) | 2021-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252477A0 (en) | 2-aminopyrimidine compound, pharmaceutical structure and its use | |
| HK1232137A1 (zh) | 治療化合物和組合物 | |
| GB201411197D0 (en) | Composition and use thereof | |
| PT3513809T (pt) | Composição medicinal compreendendo tivozanib | |
| GB201403093D0 (en) | Therapeutic compounds and their use | |
| HUE052359T2 (hu) | Hidrofluorolefin-bázisú készítmény és alkalmazása | |
| HK1213792A1 (zh) | 皮膚護理組合物 | |
| SG11201605366QA (en) | Pharmaceutical composition containing pyridylaminoacetic acidcompound | |
| SG11201608217PA (en) | Fatty acid composition and use thereof | |
| LT3094616T (lt) | Medžiagos, kurioje yra glicerilo tribenzoato, naudojimas gydant neurodegeneracinius sutrikimus | |
| HK1245086A1 (zh) | 處方藥物組成及其製備和使用 | |
| HK1231426A1 (zh) | 皮膚增白美容組合物 | |
| HK1245085A1 (zh) | 處方藥物組成及其製備和使用 | |
| HK1213793A1 (zh) | 皮膚護理組合物 | |
| IL251345A0 (en) | Preparations for use in the treatment of peri-implantitis | |
| HUE039750T2 (hu) | Hidroxi-buspiron mozgászavarok kezelésére | |
| SG11201602573RA (en) | Skin cosmetic composition | |
| PT3102187T (pt) | Composições farmacêuticas estáveis contendo sitagliptina sob a forma de comprimidos de libertação imediata | |
| ZA201704830B (en) | Cosmetic sunscreen composition | |
| IL248735B (en) | Preparations containing glycolipid for use in the treatment of tumors | |
| GB201411196D0 (en) | Composition and use thereof | |
| IL252447A0 (en) | Compound for oral care | |
| GB201513543D0 (en) | Compositions for use in the treatment of diabetes | |
| IL252994A0 (en) | Compound for oral care | |
| GB201404391D0 (en) | Novel compositions having use in therapy |